RECURRENT RESPIRATORY PAPILLOMATOSIS
Clinical trials for RECURRENT RESPIRATORY PAPILLOMATOSIS explained in plain language.
Never miss a new study
Get alerted when new RECURRENT RESPIRATORY PAPILLOMATOSIS trials appear
Sign up with your email to follow new studies for RECURRENT RESPIRATORY PAPILLOMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine hope for rare throat tumor disease
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage study tests a custom-made vaccine for people with recurrent respiratory papillomatosis (RRP), a rare condition where non-cancerous throat tumors keep coming back. The vaccine is made from the patient's own immune cells and aims to train the body to fight the viru…
Matched conditions: RECURRENT RESPIRATORY PAPILLOMATOSIS
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 03:23 UTC
-
Gene therapy retreatment aims to cut surgeries for rare throat tumor condition
Disease control Recruiting nowThis study tests whether retreating adults with recurrent respiratory papillomatosis (RRP) with a gene therapy called Zopapogene imadenovec can reduce the need for repeated surgeries to remove throat growths. It involves 30 participants in two groups: one to check how the virus v…
Matched conditions: RECURRENT RESPIRATORY PAPILLOMATOSIS
Phase: PHASE4 • Sponsor: Precigen, Inc • Aim: Disease control
Last updated May 26, 2026 03:30 UTC
-
New drug combo targets HPV-Caused throat tumors in early trial
Disease control Recruiting nowThis early-phase study tests two drugs, lenvatinib and pembrolizumab, in 20 people with HPV-related recurrent respiratory papillomatosis (RRP), a condition causing non-cancerous growths in the airway. The goal is to see if the combination shrinks lung growths and reduces the need…
Matched conditions: RECURRENT RESPIRATORY PAPILLOMATOSIS
Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Disease control
Last updated May 20, 2026 11:57 UTC